First test of gene therapy for rare form of autism is underwaynews2026-02-23T14:00:16+00:00February 23rd, 2026|Endpoints News|
Gossamer Bio’s potential Winrevair competitor fails pivotal trialnews2026-02-23T13:00:43+00:00February 23rd, 2026|Endpoints News|
Unravelling the chemistry behind the sea’s bioluminescent sparklenews2026-02-23T11:10:00+00:00February 23rd, 2026|Chemistry World|
Gilead to buy cell therapy partner Arcellx in deal valued at $7.8Bnews2026-02-23T11:06:14+00:00February 23rd, 2026|Endpoints News|
